Evidence map›Paper›PMID 25701758›Full record

ArticleBiochimica et biophysica acta2015

The calcium-sensing receptor: A promising target for prevention of colorectal cancer.

Abhishek Aggarwal, Maximilian Prinz-Wohlgenannt, Samawansha Tennakoon, Julia Höbaus, Cedric Boudot, Romuald Mentaverri, Edward M Brown, Sabina Baumgartner-Parzer, Enikö Kállay

Open access · hybridAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Low molecular weight hyaluronan inhibits lung epithelial ion channels by activating the calcium-sensing receptor.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Abhishek AggarwalDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Maximilian Prinz-WohlgenanntDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Samawansha TennakoonDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Julia HöbausDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Cedric BoudotINSERM U1088, University of Picardie Jules Verne, Amiens, France.
Romuald MentaverriINSERM U1088, University of Picardie Jules Verne, Amiens, France.
Edward M BrownDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Sabina Baumgartner-ParzerDepartment of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Enikö KállayDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria. Electronic address: enikoe.kallay@meduniwien.ac.at.
Medical University of Vienna · ATInserm · FRBrigham and Women's Hospital · US

Funding

Austrian Science Fund FWF P 22200
6 · The paper itself

Abstract

The inverse correlation between dietary calcium intake and the risk of colorectal cancer (CRC) is well known, but poorly understood. Expression of the calcium-sensing receptor (CaSR), a calcium-binding G protein-coupled receptor is downregulated in CRC leading us to hypothesize that the CaSR has tumor suppressive roles in the colon. The aim of this study was to understand whether restoration of CaSR expression could reduce the malignant phenotype in CRC. In human colorectal tumors, expression of the CaSR negatively correlated with proliferation markers whereas loss of CaSR correlated with poor tumor differentiation and reduced apoptotic potential. In vivo, dearth of CaSR significantly increased expression of proliferation markers and decreased levels of differentiation and apoptotic markers in the colons of CaSR/PTH double knock-out mice confirming the tumor suppressive functions of CaSR. In vitro CRC cells stably overexpressing wild-type CaSR showed significant reduction in proliferation, as well as increased differentiation and apoptotic potential. The positive allosteric modulator of CaSR, NPS R-568 further enhanced these effects, whereas treatment with the negative allosteric modulator, NPS 2143 inhibited these functions. Interestingly, the dominant-negative mutant (R185Q) was able to abrogate these effects. Our results demonstrate a critical tumor suppressive role of CaSR in the colon. Restoration of CaSR expression and function is linked to regulation of the balance between proliferation, differentiation, and apoptosis and provides a rationale for novel strategies in CRC therapy.

Indexed as

Amino Acid SubstitutionAniline CompoundsAnimalsApoptosisCaco-2 CellsCell DifferentiationCell ProliferationColorectal NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMice, KnockoutMutation, MissenseNaphthalenesAniline CompoundsCASR protein, humanCASR protein, mouseN-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamineN-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamineNaphthalenesPhenethylaminesPropylaminesReceptors, Calcium-SensingReceptors, G-Protein-CoupledTumor Suppressor ProteinsCalcilyticCalcimimeticCalciumCalcium-sensing receptorColonColorectal cancerTumor suppressor

Identifiers

PMID25701758
PMCPMC4549785
OpenAlexW2090544517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.